Christopher John Morl, Chief Business Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 15,034 shares at $55.00 ($827K) on 2019-12-10, disclosed to the SEC on 2019-12-11.
Open-market sale of $827k DCPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 3,387 | $186K | 22.5% |
| 2 | $55.00 | 11,647 | $641K | 77.5% |
| Total | $55.00 avg | 15,034 | $827K | 100% |
| Filing → |
| DCPH | SELL | 2020-01-06 | $1.8M | — | Filing → |
| DCPH | SELL | 2019-12-13 | $902K | — | Filing → |
| DCPH | SELL | 2019-12-05 | $752K | — | Filing → |